| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8734705 | Revista Brasileira de Hematologia e Hemoterapia | 2016 | 4 Pages |
Abstract
The early suspension of acyclovir can be safe in patients who receive autologous hematopoietic stem cell transplants. However some groups may benefit from extended prophylaxis with acyclovir, particularly older patients and patients with multiple myeloma.
Related Topics
Health Sciences
Medicine and Dentistry
Hematology
Authors
Kelli Borges dos Santos, Rafaela Souto e Souza, Angelo Atalla, Abrahão Elias Hallack-Neto,